ResearcherAffiliated Hospital of Qingdao UniversityNo recent work listed

Zequn Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-1601-7304; OpenAlex author ID A5103121039. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2021: 1 paper · 2022: 1 paper

Papers 2

TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer. Co-author DOI 10.1186/s12943-022-01626-5 ↗
A novel prognostic factor TIPE2 inhibits cell proliferation and promotes apoptosis in pancreatic ductal adenocarcinoma (PDAC). Co-author DOI 10.7150/ijms.51497 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yanbing Zhou · 2 shared papers, 2021–2022 · strength 0.31
- Paper TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer. DOI 10.1186/s12943-022-01626-5 ↗
- Paper A novel prognostic factor TIPE2 inhibits cell proliferation and promotes apoptosis in pancreatic ductal adenocarcinoma … DOI 10.7150/ijms.51497 ↗
Yuqi Sun · 2 shared papers, 2021–2022 · strength 0.31
- Paper TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer. DOI 10.1186/s12943-022-01626-5 ↗
- Paper A novel prognostic factor TIPE2 inhibits cell proliferation and promotes apoptosis in pancreatic ductal adenocarcinoma … DOI 10.7150/ijms.51497 ↗
Jun Niu · 1 shared paper, 2022 · strength 0.17
- Paper TIPE3 is a candidate prognostic biomarker promoting tumor progression via elevating RAC1 in pancreatic cancer. DOI 10.1186/s12943-022-01626-5 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.